Display options
Cite
Qvigstad C, Tait RC, de Moerloose P, et al. Hematuria in aging men with hemophilia: Association with factor prophylaxis. Res Pract Thromb Haemost. 2020;4(2):309-317doi: 10.1002/rth2.12298.
Qvigstad, C., Tait, R. C., de Moerloose, P., Holme, P. A. (2020). Hematuria in aging men with hemophilia: Association with factor prophylaxis. Research and practice in thrombosis and haemostasis, 4(2), 309-317. https://doi.org/10.1002/rth2.12298
Qvigstad, Christian, et al. "Hematuria in aging men with hemophilia: Association with factor prophylaxis." Research and practice in thrombosis and haemostasis vol. 4,2 (2020): 309-317. doi: https://doi.org/10.1002/rth2.12298
Qvigstad C, Tait RC, de Moerloose P, Holme PA. Hematuria in aging men with hemophilia: Association with factor prophylaxis. Res Pract Thromb Haemost. 2020 Jan 16;4(2):309-317. doi: 10.1002/rth2.12298. eCollection 2020 Feb. PMID: 32110762; PMCID: PMC7040553.
Copy Download .nbib Format: NLM
Share it on

Res Pract Thromb Haemost. 2020 Jan 16;4(2):309-317. doi: 10.1002/rth2.12298. eCollection 2020 Feb.

Hematuria in aging men with hemophilia: Association with factor prophylaxis.

Research and practice in thrombosis and haemostasis

Christian Qvigstad, R Campbell Tait, Philippe de Moerloose, Pål Andre Holme,

Affiliations

  1. Department of Haematology Oslo University Hospital Oslo Norway.
  2. Institute of Clinical Medicine University of Oslo Oslo Norway.
  3. Royal Infirmary Glasgow UK.
  4. University Hospital and Faculty of Medicine of Geneva Geneva Switzerland.

PMID: 32110762 PMCID: PMC7040553 DOI: 10.1002/rth2.12298

Abstract

INTRODUCTION: Macroscopic hematuria is considered a significant risk factor for urologic disease, and it is highly prevalent in people with hemophilia.

AIM: To determine whether prophylactic factor replacement therapy is associated with reduced occurrence of macroscopic hematuria in people with hemophilia in a post hoc analysis using data from a cross-sectional study conducted by the Age-Related Developments and Comobordities in Hemophilia (ADVANCE) Working Group that included males with hemophilia ≥40 years of age.

METHODS: Data from 16 contributing centers, in 13 European countries and Israel, were analyzed using logistic regression. Of 532 recruited individuals, this analysis included 370 patients with moderate or severe hemophilia who received on-demand or prophylactic therapy.

RESULTS: For patients with a history of macroscopic hematuria, we analyzed the association between prophylaxis and reoccurrence of macroscopic hematuria within the past 5 years (n = 235 patients). Frequent (≥3 times/wk) prophylaxis was negatively associated with a recent episode of macroscopic hematuria (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.18-0.76). We also analyzed whether prophylaxis corresponded to a lower lifetime number of macroscopic hematuria episodes (n = 285 patients). Frequent prophylaxis for >15 years was associated with a lower number of episodes compared to on-demand treatment (OR, 0.29; 95% CI, 0.16-0.54), whereas nonsteroidal anti-inflammatory drugs (NSAIDs) and severe hemophilia were associated with a higher number. There was no association of prophylaxis <3 times/wk with hematuria.

CONCLUSION: Frequent prophylaxis was negatively associated with the number of episodes of macroscopic hematuria in people with hemophilia. Prevalence of macroscopic hematuria was higher among individuals with severe hemophilia and those regularly using NSAIDs.

© 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis.

Keywords: aging; blood coagulation factors; hematuria; hemophilia A; hemophilia B

References

  1. J Am Soc Nephrol. 2007 Feb;18(2):414-20 - PubMed
  2. Blood Transfus. 2012 Apr;10(2):165-8 - PubMed
  3. J Thromb Haemost. 2010 Feb;8(2):269-75 - PubMed
  4. Br Med J (Clin Res Ed). 1986 Mar 8;292(6521):681-3 - PubMed
  5. Haemophilia. 2016 Jul;22(4):514-20 - PubMed
  6. Haemophilia. 2016 Jul;22(4):549-55 - PubMed
  7. Br J Gen Pract. 2015 Nov;65(640):e769-75 - PubMed
  8. Ann Intern Med. 2016 Apr 5;164(7):488-97 - PubMed
  9. J Urol. 1992 Sep;148(3):788-90 - PubMed
  10. J Thromb Haemost. 2012 Mar;10(3):359-67 - PubMed
  11. Haemophilia. 2007 Sep;13(5):489-92 - PubMed
  12. J Thromb Haemost. 2017 Nov;15(11):2115-2124 - PubMed
  13. Br Med J (Clin Res Ed). 1982 Dec 4;285(6355):1609-11 - PubMed
  14. Haemophilia. 2013 Jan;19(1):e1-47 - PubMed
  15. N Engl J Med. 2007 Aug 9;357(6):535-44 - PubMed
  16. Clin J Am Soc Nephrol. 2012 Jan;7(1):175-84 - PubMed
  17. PLoS One. 2015 May 27;10(5):e0128575 - PubMed
  18. J Thromb Haemost. 2010 Jan;8(1):83-9 - PubMed
  19. Clin J Am Soc Nephrol. 2007 Jan;2(1):51-7 - PubMed
  20. Q J Med. 1971 Jan;40(157):47-61 - PubMed
  21. Scand J Haematol Suppl. 1977;30:43-50 - PubMed
  22. Thromb Haemost. 2012 Oct;108(4):750-5 - PubMed
  23. Medicine (Baltimore). 2018 Sep;97(39):e12551 - PubMed
  24. Clin Radiol. 1972 Jul;23(3):349-54 - PubMed
  25. Thromb Haemost. 2015 Jul;114(1):35-45 - PubMed
  26. Urol Clin North Am. 1998 Nov;25(4):661-76 - PubMed
  27. J Thromb Haemost. 2011 Apr;9(4):700-10 - PubMed
  28. Haemophilia. 2016 Mar;22(2):248-255 - PubMed
  29. BMC Nephrol. 2018 Jun 26;19(1):150 - PubMed
  30. Haemophilia. 2003 Nov;9(6):703-10 - PubMed
  31. Haemophilia. 2010 Jul 1;16(4):683-5 - PubMed

Publication Types